Healthcare -
Biotechnology - NASDAQ - US
$ 18.05
2.67 %
$ 1.24 B
Market Cap
-3.77
P/E
Price Target
Average
266.44%
Revenue Forecast
Estimate
94.52%
EBIT
Estimate
--12.90%
Net Income
Estimate
42.98%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Arvinas, Inc.
Wall Street analysts predict an average 1-year price target for ARVN of $66.1 , with forecasts ranging from
a
low of
$40 to a high of $87 .
ARVN Lowest Price Target
Wall Street Target
40 USD
121.61%
ARVN Average Price Target
Wall Street Target
66.1 USD
266.44%
ARVN Highest Price Target
Wall Street Target
87 USD
381.99%
REVENUE FORECAST
Revenue Forecast Chart ARVN
EBIT FORECAST
EBIT Forecast Chart ARVN
NET INCOME FORECAST
Net Income Chart ARVN